AstraZeneca CFO says company is developing a GLP-1 pill
Aradhana Sarin, AstraZeneca CFO, joined “Squawk Box” to discuss the company’s drug pipeline outlook, including the development of a GLP-1 pill.
Aradhana Sarin, AstraZeneca CFO, joined “Squawk Box” to discuss the company’s drug pipeline outlook, including the development of a GLP-1 pill.
